Simon S. Wing
Montreal, QC H4A3J1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Ubiquitin-specific peptidase-19 links TDP-43 aggregation to ER stress.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 10, 2026
Effect of inactivation of the USP19 deubiquitinase gene in mice on important phenotypes of aging.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: October 27, 2025
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes.
Journal: Diabetologia
Published: December 23, 2024
α-Synuclein ubiquitination - functions in proteostasis and development of Lewy bodies.
Journal: Frontiers in molecular neuroscience
Published: September 19, 2024
Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysis.
Journal: Diabetes, obesity & metabolism
Published: May 11, 2023
USP19 deubiquitinase inactivation regulates α-synuclein ubiquitination and inhibits accumulation of Lewy body-like aggregates in mice.
Journal: NPJ Parkinson's disease
Published: November 21, 2022
Association of Low Muscle Mass With Cognitive Function During a 3-Year Follow-up Among Adults Aged 65 to 86 Years in the Canadian Longitudinal Study on Aging.
Journal: JAMA network open
Published: July 07, 2022
Interactions of the super complexes: When mTORC1 meets the proteasome.
Journal: The international journal of biochemistry & cell biology
Published: August 28, 2019
Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.
Journal: Journal of cachexia, sarcopenia and muscle
Published: October 15, 2018
The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice.
Journal: Diabetologia
Published: July 09, 2018
The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
Journal: EMBO molecular medicine
Published: May 31, 2018
FAM210A is a novel determinant of bone and muscle structure and strength.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 06, 2018
Last Updated: 09/26/2026